Dosimetry Performance Research Articles

Novel non-thermoluminescent CaSO4:Dy dosimeters

The non-thermoluminescence afterglow-based dosimetry performance of self-agglomerating pellet-shaped CaSO4:Dy phosphors synthesized through a low-cost, environmentally friendly method is first reported. Thermoluminescence (TL) and afterglow (AG) were analyzed in samples exposed to beta particle irradiation in the dose range from 0.06 to 8.0 Gy. Characteristic TL glow curves consist of an intense TL maximum at 134 °C, a shoulder at 200 °C, and a maximum at 447 °C. CaSO4:Dy exhibits a highly sensitive AG response for 24 hours with linear behavior from 0.06 Gy to 8.0 Gy. A remarkable reproducibility of both the TL and the AG response was observed in repeated irradiation–readout cycles with no need for pre-irradiation annealing. The synthesized CaSO4:Dy exhibits promising properties to be used as an AG-based dosimeter for real-time radiation detection and dosimetry. Moreover, this phosphor might be applied as a long persistent phosphor (LPP), being a cost-effective alternative to other available LPPs.

Impact of sample preparation temperature on Li and Ce co-doped MgB4O7 dosimetry performance: A plausible scenario for controlling defect clustering

MgB4O7 co-doped with Ce and Li has been recognized as a promising dosimetric material for spatially-resolved optically stimulated luminescence (OSL) measurements. Nevertheless, conflicting information exists in the literature regarding its dosimetric characteristics. These include discrepancies in fading, the proportion of shallow traps, the range of linear dose response, and a notable absence of direct sensitivity comparisons. These discrepancies are likely attributed to variations in the synthesis methods utilized to produce this material. As part of our research initiative aiming at elucidating the influence of synthesis on the luminescence properties, we are examining in this contribution a single parameter – specifically, the sample preparation temperature – and assessing its impact on the luminescence properties. For the first time, we identified a correlation between the width of the thermoluminescence (TL) glow curves, the TL, optically stimulated luminescence (OSL), and radioluminescence (RL) intensities, as well as the fading characteristics over time and annealing temperature. We show that annealing at higher temperature leads to narrowing of the main TL peak (c.a. 240 °C at 5 °C/s heating rate) compared with samples prepared at lower temperatures, which in turn leads to a decrease in the integrated TL intensity of that peak. Despite exhibiting lower intensity, samples prepared at temperatures above 800 °C show less than 10 % TL/OSL fading over 60 days. Our measurements suggest an involvement of clustered defects for the samples prepared at 600 °C, with a shift towards a scenario of delocalized transitions in samples prepared at higher temperatures.

A cone-beam optical CT based on a convergent light source – Characterization and optimization

PurposeEmploying a Fresnel lens and a point-like light source to create a convergent light beam for the camera effectively minimizes stray light and enhances image quality in optical computed tomography (OCT), benefiting 3D dosimetry applications. This study outlines the development of an economical cone-beam optical computed scanner for 3D dosimetry. MethodsOptical performance was assessed by calculating modulation transfer function (MTF) with pattern charts. Stray light was evaluated by imaging a cylinder flask and a square grid with 5 mm diameter holes to determine the stray-to-primary ratio. Reconstruction quality was determined using SIRT-TV and compared with spectrophotometry attenuation coefficients, with the best regularization parameter (λ = 0.01) chosen based on contrast-to-noise ratio (CNR). Dosimetry performance was assessed by determining percentage dose depth (PDD) for a 6MV beam with a 5 × 5 cm2 field using FXO-f gel dosimeter, compared with ionization chamber data. ResultsMTF evaluation yielded ≥ 50 % agreement with pattern charts. Stray-to-primary ratio was less than 0.1 or 10 % of the total signal. Reconstruction showed low noise and artifacts, with optimal CNR at λ = 0.01. Attenuation coefficients from optical CT aligned with spectrometer measurements within 1.2 %. PDD calculated with FXO-f gel dosimeter closely matched ionization chamber data (<1.2 % difference), achieving a dose resolution of 0.1 Gy. ConclusionThe built and optimization the de optical-CT based on a convergent beam is read to perform the 3D quality assurance in clinical applications.

Quantitative evaluation of 90Y-PET/CT and 90Y-SPECT/CT-based dosimetry following Yttrium-90 radioembolization.

Following yttrium-90 radioembolization (90Y-RE), 90Y-PET/CT and 90Y-SPECT/CT imaging provide the means to calculate the voxelized absorbed dose distribution. Given the widespread use of the two imaging modalities and lack of well-established standardized dosimetry protocols for 90Y-RE, there is a clinical need to systematically investigate and evaluate differences in the performance of voxel-based dosimetry between 90Y-PET/CT and 90Y-SPECT/CT. To quantitatively analyze and compare 90Y-PET/CT and 90Y-SPECT/CT-based dosimetry following 90Y-RE. 90Y-PET/CT and90Y-SPECT/CT imaging was acquired for 35 patients following 90Y-RE with TheraSphere for the treatment of unresectable hepatocellular carcinoma. Dosimetry was performed using the local deposition method with known activity and the mean dose (Dmean) was calculated for perfused liver volumes (PV), tumors (T), and perfused normal livers (NL). Additionally, the absorbed dose to x% of the volume (Dx, x [5%, 10%, …, 90%, 95%]) and the volume receiving y Gy (Vy, y [10Gy, 20Gy, …, 190Gy, 200Gy]) were calculated for T and NL, respectively. Dose metrics were compared using linear regression, Bland-Altman analysis, and statistical testing. Both 90Y-SPECT/CT and 90Y-PET/CT-based tumor Dmean were strongly correlated (R2 ≥ 0.90) with Dx, excluding metrics on the extrema. Intra-modality comparisons of various Dx and Vy metrics yielded statistically significant differences (ANOVA, p<0.001) for both90Y-PET/CT and90Y-SPECT/CT. Based on statistical testing, only Dx metrics separated by greater than 20%-30% coverage, and only Vy metrics separated by greater than 40-70Gy, reported significant differences. For PV, there was a strong correlation (R2 ≥ 0.99) between Dmean derived separately from 90Y-PET/CT and 90Y-SPECT/CT imaging. The strength of the correlation was slightly reduced for T and NL with R2=0.91 and R2=0.95, respectively. For PV, the mean bias±standard error (SE) and 95% limits of agreement (LOA) between Dmean from the two modalities was effectively zero with -0.8±0.4% (±2.5%). For T and NL, the mean bias±SE (±LOA) was -14.5±3.7% (±24%) and 9.4±4.7% (±27%), respectively. The strong correlation between Dmean and Dx suggests information from multiple dose metrics (e.g., D70 and Dmean) is largely redundant when establishing dose-response relationships in 90Y-RE. Dmean is highly correlated between 90Y-PET/CT and 90Y-SPECT/CT-based dosimetry, for all liver VOIs. Relative to 90Y-SPECT/CT, 90Y-PET/CT, on average, yielded higher Dmean to tumors (14%) and lower Dmean to perfused normal livers (9%). Absorbed dose differences for perfused liver volumes between 90Y-SPECT/CT and 90Y-PET/CT were negligible.

A novel method for rapid estimation of active bone marrow dose for radiotherapy patients in epidemiological studies.

In a dedicated effort to improve the assessment of clonal hematopoiesis (CH) and study leukemia risk following radiotherapy, we are developing a large-scale cohort study among cancer patients who received radiation. To that end, it will be critical to analyze dosimetric parameters of red bone marrow (ABM) exposure in relation to CH and its progression to myeloid neoplasms, requiring reconstruction method for ABM doses of a large-scale patients rapidly and accurately. To support a large-scale cohort study on the assessment of clonal hematopoiesis and leukemia risk following radiotherapy, we present a new method for the rapid reconstruction of ABM doses of radiotherapy among cancer patients. The key idea of the presented method is to segment patient bones rapidly and automatically by matching a whole-body computational human phantom, in which the skeletal system is divided into 34 bone sites, to patient CT images via 3D skeletal registration. The automatic approach was used to segment site-specific bones for 40 radiotherapy patients. Also, we segmented the bones manually. The bones segmented both manually and automatically were then combined with the patient dose matrix calculated by the treatment planning system (TPS) to derive patient ABM dose. We evaluated the performance of the automatic method in geometric and dosimetric accuracy by comparison with the manual approach. The pelvis showed the best geometric performance [volume overlap fraction (VOF): 52% (mean) with 23% (σ) and average distance (AD): 0.8cm (mean) with 0.5cm (σ)]. The pelvis also showed the best dosimetry performance [absorbed dose difference (ADD): 0.7Gy (mean) with 1.0Gy (σ)]. Some bones showed unsatisfactory performances such as the cervical vertebrae [ADD: 5.2Gy (mean) with 10.8Gy (σ)]. This impact on the total ABM dose, however, was not significant. An excellent agreement for the total ABM dose was indeed observed [ADD: 0.4Gy (mean) with 0.4Gy (σ)]. The computation time required for dose calculation using our method was robust (about one minute per patient). We confirmed that our method estimates ABM doses across treatment sites accurately, while providing high computational efficiency. The method will be used to reconstruct patient-specific ABM doses for dose-response assessment in a large cohort study. The method can also be applied to prospective dose calculation within a clinical TPS to support clinical decision making at the point of care.

Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy.

The aim of this study was to investigate the accuracy of single-time-point (STP) renal dosimetry imaging using SPECT/CT data, a nonlinear mixed-effects (NLME) model, and a population-based model selection (PBMS) in a large population for 177Lu-labeled prostate-specific membrane antigen therapy. Methods: Biokinetic data (mean ± SD) of [177Lu]Lu-PSMA-617 in kidneys at time points 1 (1.8 ± 0.8 h), 2 (18.7 ± 0.9 h), 3 (42.6 ± 1.0 h), 4 (66.3 ± 0.9 h), and 5 (160.3 ± 24.2 h) after injection were obtained from 63 patients with metastatic castration-resistant prostate cancer using SPECT/CT. Thirteen functions were derived from various parameterizations of 1- to 5-exponential functions. The function's parameters were fitted in the NLME framework to the all-time-point (ATP) data. The PBMS NLME method was performed using the goodness-of-fit test and Akaike weight to select the best function fitting the data. The best function from ATP fitting was used to calculate the reference time-integrated activity and absorbed doses. In STP dosimetry, the parameters of a particular patient with STP data were fitted simultaneously to the STP data at different time points of that patient with ATP data of all other patients. The parameters from STP fitting were used to calculate the STP time-integrated activity and absorbed doses. Relative deviations (RDs) and root-mean-square errors (RMSEs) were used to analyze the accuracy of the calculated STP absorbed dose compared with the reference absorbed dose obtained from the best-fit ATP function. The performance of STP dosimetry using PBMS NLME modeling was compared with the Hänscheid and Madsen methods. Results: The function [Formula: see text] was selected as the best-fit ATP function, with an Akaike weight of 100%. For STP dosimetry, the STP measurement by SPECT/CT at time point 3 (42.6 ± 1.0 h) showed a relatively low mean RD of -4.4% ± 9.4% and median RD of -0.7%. Time point 3 had the lowest RMSE value compared with those at the other 4 time points. The RMSEs of the absorbed dose RDs for time points 1-5 were 23%, 16%, 10%, 20%, and 53%, respectively. The STP dosimetry using the PBMS NLME method outperformed the Hänscheid and Madsen methods for all investigated time points. Conclusion: Our results show that a single measurement of SPECT/CT at 2 d after injection might be used to calculate accurate kidney-absorbed doses using the NLME method and PBMS.

Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer.

Purpose: This prospective study investigated the incidence of radiation pneumonitis (RP) after immunotherapy followed by radiotherapy in non-small-cell lung cancer, analyzed the risk factors for RP, and explored the predictive performance of dosimetry and dosiomics. Methods & materials: Risk factors for grade ≥2 RP were calculated by using a logistic regression model. Predictive performance was compared on the basis of area under thecurvevalues. Results: Grade ≥2 RP occurred in 16 cases (26.7%). The AUC values of V5Gy, gray-level dependence matrix-small dependence high gray-level emphasis (GLDM-SDHGLE)and combined features were 0.685, 0.724and 0.734, respectively. Conclusion: Smoking history, bilateral lung V5Gyand GLDM-SDHGLE were independent risk factors for RP. Dosiomics can effectively predict RP.

Determination of the Absorbed Dose in Water for Small Photon Beams Using Micro-TLDs of LiF:Mg,Ti (Pilot Audit Proposal)

Background: Small-field dosimetry remains an open challenge globally. Thus, it is crucial to consider adequate reference codes of practice for the performance of dosimetry. Furthermore, as part of good clinical practice, the implementation of new codes of practice implies the development of a dosimetry audit program. In this work, a pilot dosimetric audit protocol is established for measuring the absolute dose in water for small fields using micro-TLDs LiF:Mg,Ti dosimeters. Methods: The dosimeters were irradiated with a 6 MV X-ray beam in a linear accelerator. The TLDs were calibrated between 0.5 and 3 Gy for different field sizes. For audit, the TLDs were irradiated at 2 Gy for different circular field sizes. The proposed protocol consists of five TLD dosimeters forming a cross with a marked radiochromic film to identify the position of the central dosimeter during irradiation. Only the dosimeter measurement in the center of the field is used. Results: It was found that the percentage difference between the measured dose and the prescribed dose (2 Gy) for irradiation in circular fields is less than 3%. Conclusions: A pilot dosimetric audit was carried out using the proposed protocol over a linear accelerator using small circular collimator photon beams.

Comparison of ArcCHECK and portal dosimetry in dose verification for intensity modulated radiotherapy plan for craniospinal irradiation

BackgroundTo study the performance of ArcCHECK system and Portal Dosimetry (PD) used for dose verification in intensity-modulated radiotherapy (IMRT) plan of the craniospinal irradiation (CSI). Materials and MethodsA total of 12 IMRT verification plans were produced for patients who underwent CSI treatment. Each verification plan consists of three isocenter plans corresponding to head and neck (H&N), thorax, and abdomen. With different analysis criterion, ArcCHECK and PD were used for verification, and differences in the γ passing rate of verification system were evaluated using paired-samples t-test/Wilcoxon matched-pairs signed rank test. ResultsWith the criterion of 3%/3 mm, there was no significant difference in the average γ passing rates between H&N and abdomen (P > 0.05), but there was statistically significant difference in the average γ passing rate of the thorax (P < 0.05); With the criterion of 3%/2 mm, there was no significant difference in the passing rate (P > 0.05), but there was statistically significant difference in the passing rates of thorax, abdomen and pelvis(P < 0.05). When the 2%/2 mm criterion was used, the difference in the passing rates of the H&N/thorax/abdomen was statistically significant (P < 0.05). ConclusionsBoth ArcCHECK and PD can be used for the dose verification of the craniospinal irradiation plan. The PD method is superior to ArcCHECK in the verification efficiency and verification accuracy. It is recommended to use the criterion of 3%/3 mm or 3%/2 mm for ArcCHECK, and 3%/2 mm or 2%/2 mm criterion for Portal Dosimetry.

Consequences of doping Er3+ and Yb3+ ions on the thermoluminescence dosimetry performance of the BaO-ZnO-LiF-B2O3-Sm2O3 glass system

The consequences of doping Er3+ and Yb3+ ions on the thermoluminescence (TL) dosimetry performance of the BaO-ZnO-LiF-B2O3-Sm2O3 glass system were examined for the first time. The incorporation of Er3+ and Yb3+ ions were found to be highly detrimental to the TL intensity, sensitivity, and trap density of the Sm3+ doped glass. Although Sm3+ ions enhanced the integrated TL intensity of the host glass by two thousand times, Sm3+-Er3+ and Sm3+-Yb3+ combinations functioned like activator-quencher systems. Contrary, the problem of anomalous loss of 50% signal after a storage week of the Sm3+ doped glass was effectively countered by doping Er3+ (2% loss) and Yb3+ (8% loss) ions. From the trap parameters, the elimination of some shallow traps and deepening of some existing ones was reasoned for minimizing fading. Even if the Er3+ and Yb3+ ions adversely affected the TL intensity of the Sm3+ glass, they greatly improved the stability. The observations indicate that the TL dosimetry performance of a glass system can be suitably tuned by the doping/co-doping of rare-earth ions.

Dynamic OCT Signal Loss for Determining RPE Radiant Exposure Damage Thresholds in Microsecond Laser Microsurgery

Optical microsurgery of the retinal pigment epithelium (RPE) requires reliable real-time dosimetry to prevent unwanted overexposure of the neuroretina. The system used in this experiment implements optical coherence tomography (OCT) to detect the intentional elimination of RPE cells. We evaluated the performance of OCT dosimetry in terms of its ability to detect RPE cell damage caused by microsecond laser pulses of varying duration. Therefore, ex-vivo porcine RPE choroid sclera explants were embedded in an artificial eye and exposed to single laser pulses of 2–20 µs duration (wavelength: 532 nm, exposure area: 120 × 120 µm2, intensity modulation factor: 1.3). Simultaneously, time-resolved OCT M-scans were recorded (central wavelength: 870 nm, scan rate: 33 kHz). Post-irradiation, RPE cell damage was quantified using a calcein-AM viability assay and compared with an OCT-dosimetry algorithm. The results of our experiments show that the OCT-based analysis successfully predicts RPE cell damage. At its optimal operating point, the algorithm achieved a sensitivity of 89% and specificity of 94% for pulses of 6 µs duration and demonstrated the ability to precisely control radiant exposure of a wide range of pulse durations towards selective real-time laser microsurgery.

Dual-storage phosphor proton therapy dosimetry: Simultaneous quantification of dose and linear energy transfer.

To investigate the feasibility of using the high Zeff storage phosphor material BaFBrI:Eu2+ in conjunction with the low Zeff storage phosphor material KCl:Eu2+ for simultaneous proton dose and linear energy transfer (LET) measurements by (a) measuring the fundamental optical and dosimetric properties of BaFBrI:Eu2+ , (b) evaluating its compatibility in being readout simultaneously with KCl:Eu2+ dosimeters, and (c) modeling and validating its LET dependence under elevated proton LET irradiation. A commercial BaFBrI:Eu2+ storage phosphor detector (Model ST-VI, Fujifilm) was characterized with energy dispersive x-ray spectroscopy (EDS) analysis to obtain its elemental composition. The dosimeters were irradiated using both a Mevion S250 proton therapy unit (at the center of a spread-out Bragg peak, SOBP) and a Varian Clinac iX linear accelerator with the latter being a low LET irradiation. The photostimulated luminescence (PSL) emission spectra, excitation spectra, and luminescent lifetimes of the detector were measured after proton and photon irradiations. Dosimetric properties including dose linearity, dose rate dependence, radiation hardness, temporal, and readout stabilities were studied using a laboratory optical reader after proton irradiations. In addition, its proton energy dependence was analytically modeled and experimentally validated by irradiating the detectors at various depths within the SOBP (Range: 15.0g/cm2 , Modulation: 10.0g/cm2 ). The active detector composition for the high Zeff storage phosphor detector was found to be BaFBr0.85 I0.15 :Eu2+ . The BaFBr0.85 I0.15 :Eu2+ material's excitation and emission spectra were in agreement under proton and photon irradiations, with peaks of 586±1nm and 400±1nm, respectively, with a full width at half maximum (FWHM) of 119±3nm and 30±2nm, respectively. As dosimeter response under photon irradiation is generally believed to be free from LET effect, these results suggest LET independence of charge storage center types resulted from ionizing radiations. There is sufficient spectral overlaps with KCl:Eu2+ dosimeters allowing both dosimeters to be readout under equivalent readout conditions, that is, 594nm stimulation and 420nm detection wavelengths. Its PSL characteristic lifetime was found to be less than 5 microseconds which would make it suitable for fast 2D readout post irradiation. Its 420nm emission band intensity was found to be linear up to 10Gy absolute proton dose under the same irradiation conditions, dose rate independent, stable in time and under multiple readouts, and with high radiation hardness under cumulative proton dose histories up to 200Gy as tested in this study. BaFBr0.85 I0.15 :Eu2+ showed significant proton energy-dependent dose under-response in regions of high LET which could be modeled by stopping power ratio calculations with an accuracy of 3% in low LET regions and a distance-to-agreement (DTA) of 1mm in high LET regions (>5keV/μm). We have proven the feasibility of dual-storage phosphor proton dosimetry for simultaneous proton dose and LET measurements. BaFBr0.85 I0.15 :Eu2+ has shown equally excellent dosimetry performance as its low Zeff complement KCl:Eu2+ with distinctive LET dependence merely as a result of its higher Zeff . These promising results pave the way for future studies involving simultaneous proton dose and LET measurements using this novel approach.

Preliminary Experiences with the Rexon UL-320-FDR: An Automated Thermoluminescent Dosimeter Reader with Removable Contact Heating Planchets and an Infrared Temperature Feedback System.

The Rexon UL-320 FDR is a novel resistive-heating thermoluminescent dosimeter reader with a unique temperature measurement system and an automated dosimeter processing mechanism. The removable contact heating planchets have black-body adhesives on the back for capturing temperature information with infrared sensors. A heating cycle feedback loop ensures accurate, precise, and reproducible heating sequences. Heating rates between 0.8 and 40°C s-1 for up to 1,000 s are possible. Photomultiplier tube sensitivity and drift, dark current counts, and planchet glow were measured experimentally. Additionally, 25 LiF:Mg,Ti dosimeters were calibrated to demonstrate reader performance. Sensitivity was optimized at 1,200 V, which produced the highest reference light count to dark current count ratio while extending photomultiplier tube life. Dark current counts measured with typical time-temperature profiles for LiF:Mg,Ti were below 10 counts per channel but increased by up to 2.5% for more extreme heating cycles. Reader sensitivity drifts of up to 10% were observed during extended automated operations with typical time-temperature profiles. Total counts resulting from planchet glow decreased with faster heating rates. Calibrations performed with LiF:Mg,Ti dosimeters yielded results comparable to more established reader designs. Spikes were observed in ~3% of the glow curves from planchet dust and oil burning off at elevated temperatures. The use of N2 gas and sensitivity drift corrections are recommended to improve dosimetry performance for the UL-320 FDR reader.

Dosimetry of tumor targeting imaging by convergent X-ray beam as compared with nuclear medicine

During decades nuclear medicine procedures, based on radiolabeled agents, have proved to be efficient for diseases diagnosis and treatment. Radiation emerging from patient is detected aimed at localizing radiotracer distribution that is further correlated with biochemical/metabolic physiological processes. However, a significant drawback associated with current nuclear medicine procedures implementing radionuclide infusion regards to the inherent absorbed dose as well as radiopharmaceuticals' production, storage and elimination from patient body, thus representing a risk at patient and public health level.In the recent years, alternative methods have been proposed to reduce/eliminate radionuclides in some nuclear medicine procedures. The combination of high atomic number nanoparticles infused within patient body with incident X-ray beam, like tumor targeting and treatment, appears as a potential alternative method capable of theranostics. The process is based on inducing X-ray fluorescence and secondary electrons emission in high atomic number nanoparticles by means of excitation with an external X-ray beam, avoiding employing radioactive substances.The present work reports on the dosimetry performance of both methods, comparing whenever the external convergent X-ray beam alternative may involve less or larger radiation dose levels, according to comparable signal/image quality during the procedure. To this aim, a simplified theoretical model is proposed and associated Monte Carlo simulations are performed in order to compare typical case of nuclear medicine imaging with potential performance of an innovative method, called OXIRIS (Orthovoltage X-ray Induced Radiation and Integrated System), based on convergent X-ray beam exciting high atomic number nanoparticles infused in patient.The obtained results support the proposed alternative method's feasibility, once demonstrated that patient absorbed dose levels are relative similar to those currently used by nuclear medicine procedures, whereas dose to targeted region (tumor) are significantly higher, which may be useful for treatment purposes.

Dose uncertainty and resolution of polymer gel dosimetry using an MRI guided radiation therapy system’s onboard 0.35 T scanner

Magnetic Resonance Imaging (MRI) scanners are widely used for 3D gel dosimeters readout. However, limited access to MRI scanners is a challenge in MRI-based gel dosimetry. Recent clinical implementation of MRI-guided radiation therapy machines provides potential opportunities for onboard gel dosimetry using its MRI subsystem. The objective of this study was to investigate the feasibility of gel dosimetry using ViewRay’s onboard 0.35 T MRI scanner. A BANG® polymer gel dosimeter was irradiated by three beams of 3 × 3 cm2 field size. The T2 relaxation rate (R2) of the irradiated gel was measured using a Philips 1.5 T Ingenia MRI and a ViewRay 0.35 T onboard MRI and spin-echo pulse sequences. The number of signal averages (NSA) was set to 16 for the ViewRay acquisitions and one for the Philips 1.5 T MRI to achieve similar signal-to-noise ratios. The in-plane spatial resolution was 1.5 × 1.5 mm2 and the slice thickness was 5 mm. The relative dose uncertainty was obtained using R2 versus dose curves to compare the performance of dosimetry using the two different MRIs and field strengths. The dose uncertainty decreased from 12% at 2 Gy to 3.5% at 7.5 Gy at 1.5 T. The dose uncertainty decreased from 13% at 2 Gy to 4% at 7.5 Gy with NSA = 16 and 3 × 3 mm2 pixel size, and from 10.5% at 2 Gy to 3.2% at 7.5 Gy with NSA = 16 and denoised R2 maps (1.5 × 1.5 mm2 pixel size) at 0.35 T. The mean of dose resolution was 0.4 Gy at 1.5 T while the mean of dose resolution was 0.8 Gy and 0.64 Gy at 0.35 T by downsampling and denoising the R2 map, respectively. Therefore, comparable dose uncertainty was achievable using the ViewRay’s onboard 0.35 T and Philips 1.5 T MRI scanners. 3D gel dosimetry using onboard low-field MRI scanner provides ViewRay users a 3D high resolution dosimetry option besides film and ionization chamber.

Optically stimulated luminescence dosimetry performance of novel MgO–La(OH)3 phosphors

The aim of this work was to study the optically stimulated luminescence (OSL) properties of novel MgO co-doped with different lanthanides and lithium ions as well as to evaluate the feasibility of using the mentioned phosphors as OSL dosimeters. In this context, the OSL efficiency corresponding to different stimulation wavelengths and different filters was analyzed for all the samples. The properties of the most efficient material, namely, MgO–La(OH)3, were further studied. Moreover, the repeatability and linearity of the OSL response, the fading of the OSL signal and the minimum detectable dose were investigated. Finally, feasibility of using these compounds in OSL dosimetry was assessed.

Experimental validation of the FLUKA Monte Carlo code for dose and -emitter predictions of radioactive ion beams

In the context of hadrontherapy, whilst ions are capable of effectively destroying radio resistant, deep seated tumors, their treatment localization must be well assessed to ensure the sparing of surrounding healthy tissue and treatment effectiveness. Thus, range verification techniques, such as online positron-emission-tomography (PET) imaging, hold great potential in clinical practice, providing information on the in vivo beam range and consequent tumor targeting. Furthermore, emitting radioactive ions can be an asset in online PET imaging, depending on their half-life, compared to their stable counterparts. It is expected that using these radioactive ions the signal obtained by a PET apparatus during beam delivery will be greatly increased, and exhibit a better correlation to the Bragg Peak. To this end, FLUKA Monte Carlo particle transport and interaction code was used to evaluate, in terms of annihilation events at rest and dose, the figure of merit in using emitter, radioactive ion beams (RI). For this purpose, the simulation results were compared with experimental data obtained with an openPET prototype in various online PET acquisitions at the Heavy Ion Medical Accelerator in Chiba (HIMAC), in collaboration with colleagues from the National Institute of Radiological Sciences’ (NIRS) Imaging Physics Team. The dosimetry performance evaluation with FLUKA benefits from its recent developments in fragmentation production models. The present work estimated that irradiations with RI, produced via projectile fragmentation and their signal acquisition with state-of-the-art PET scanner, lead to nearly a factor of two more accurate definition of the signals’ peak position. In addition to its more advantageous distribution shape, it was observed at least an order magnitude higher signal acquired from 11C and 15O irradiations, with respect to their stable counterparts.

Imaging performance of a dedicated radiation transparent RF coil on a 1.0 Tesla inline MRI-linac

This work describes the first imaging studies on a 1.0 Tesla inline MRI-Linac using a dedicated transmit/receive RF body coil that has been designed to be completely radio transparent and provide optimum imaging performance over a large patient opening.A series of experiments was performed on the MRI-Linac to investigate the performance and imaging characteristics of a new dedicated volumetric RF coil: (1) numerical electromagnetic simulations were used to measure transmit efficiency in two patient positions; (2) image quality metrics of signal-to-noise ratio (SNR), ghosting and uniformity were assessed in a large diameter phantom with no radiation beam; (3) radiation induced effects were investigated in both the raw data (k-space) and image sequences acquired with simultaneous irradiation; (4) radiation dose was measured with and without image acquisition; (5) RF heating was studied using an MR-compatible fluoroptic thermometer and; (6) the in vivo image quality and versatility of the coil was demonstrated in normal healthy subjects for both supine and standing positions.Daily phantom measurements demonstrated excellent imaging performance with stable SNR over a period of 3 months (42.6 ± 0.9). Simultaneous irradiation produced no statistical change in image quality (p > 0.74) and no interference in raw data for a 20 × 20 cm radiation field. The coil was found to be efficient over large volumes and negligible RF heating was observed. Volunteer scans acquired in both supine and standing positions provided artefact free images with good anatomical visualisation.The first completely radio transparent RF coil for use on a 1.0 Tesla MRI-Linac has been described. There is no impact on either the imaging or dosimetry performance with a simultaneous radiation beam. The open design enables imaging and radiotherapy guidance in a variety of positons.

Dosimetric evaluation employing TL and OSL techniques with different luminescent materials for clinical evaluation of extremity doses using electron beams applied to Total-Irradiation-of-Skin treatments

Total-skin electron beam (TSEB) irradiation is used to deliver a homogeneous dose distribution over the entire skin surface of a patient. TSEB dosimetry is quite complex as to the evaluation and measurement of absorbed dosage in the cutaneous region. This paper evaluates the performance of different dosimetric materials, using TL and OSL dosimetry, in the extremity-dose assessment of TSEB treatments using the six-dual-field technique and an anthropomorphic phantom. Dosimeters were selected with repeatability better than [Formula: see text] and calibrated to 6-MeV electron-beam dosimetry. Measurements were conducted in the abdominal region as a reference point and on the extremities. Results show expected deviations ranging up to [Formula: see text] in the dose received in the extremities and good results in dose assessment using all dosimetric materials tested.

Afterglow dosimetry performance of beta particle irradiated lithium zirconate

In this work, we report for the very first time on the thermoluminescence (TL) and afterglow (AG) properties of Li2ZrO3. The ternary oxide Li2ZrO3 was synthesized by solid state reaction of a mixture of Li2CO3 and ZrO2 subjected to thermal annealing at 400°C for 2h and 1000°C during 24h in air. The characteristic glow curves of beta particle irradiated samples exhibit an intense TL emission located around 150°C. From the shape of the TL curve, a 0.4 form factor was determined, suggesting that first order kinetics processes are involved. The afterglow decay curves were recorded after exposure to beta particle irradiation in the dose range from 0.5 up to 2kGy. The AG integrated in the time interval from 510 to 600s after radiation exposure shows a linear dependence as a function of the irradiation dose from 0.5 up to 256Gy. A method is proposed to compute the lower detection limit and the AG sensitivity and applied to the studied phosphors. Structural and morphological characterization were carried out by X-ray diffraction and Scanning Electron Microscopy, respectively. From the results presented, it is concluded that the AG response of the synthesized Li2ZrO3 presents features suitable to develop radiation detectors and dosimeters.